Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer (Q39983076)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer |
scientific article |
Statements
1 reference
Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer (English)
1 reference
Mark J McKeage
1 reference
Martin Reck
1 reference
Michael B Jameson
1 reference
Mark A Rosenthal
1 reference
David Gibbs
1 reference
Paul N Mainwaring
1 reference
Lutz Freitag
1 reference
Richard Sullivan
1 reference
Joachim Von Pawel
1 reference
5 May 2009
1 reference
1 reference
65
1 reference
2
1 reference
192-197
1 reference
Identifiers
1 reference
1 reference